Although smoking cigarettes is generally harmful to your health, people have been smoking since 5000 BC and many people find it so difficult to quit smoking despite many alternatives available to combat the smoking habit. A study conducted in 2013 at the University College London revealed that Cannabidiol which is the second most active ingredient in marijuana can reduce cigarette addiction. It’s proven that CBD lessens the withdrawal symptoms of smoking cigarettes, thus making the quitting process easily manageable.

When one stops smoking, the brain constantly craves for reinforcements to compensate the reduced intake of nicotine. CBD elements combat that and allow for reduction of negative symptoms that come with withdrawal symptoms. Since the research findings are limited to only one study, it’s still not clear whether Cannabis is a proven solution to those who want to quit smoking.

Marijuana seems to be a natural alternative for people who want to quit smoking tobacco. Since nicotine releases the brain’s happy chemicals known as dopamine that causes an addiction, marijuana can also arouse dopamine chemicals without causing the harmful side effects that are associated with smoking cigarettes.

Marijuana is also the best option for those seeking ways to treat their addiction to heroin, opiates, tobacco, and other drugs. Marijuana can also be helpful in curbing the smoking addiction especially if one considers reasons why people smoke. Stress and Anxiety Relief many people smoke to reduce stress and anxiety. Cannabis is known to have elements that slow down the anxiety.

Additionally, there are three proven herbs that can reduce the nicotine craving, these include; Avena Sativa (derived from wild oats), Lobelia (a toxic plant that is consumed in tiny portions to fool the body system), and Garcinia Cambogia (that combats the weight gain that comes with quitting nicotine).

Although the previous studies on the topic are essential, there’s still more to be done so as to prove whether Cannabis can help reduce the effects of nicotine for those trying to quit smoking.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of journaltranscript.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure

<!–

Trending Stock News

–>

American Assets Investment Management Llc increased Deutsche Bank Ag (DB) stake by 50% reported in 2017Q2 SEC filing. American Assets Investment Management Llc acquired 50,000 shares as Deutsche Bank Ag (DB)’s stock rose 9.91%. The American Assets Investment Management Llc holds 150,000 shares with $2.67M value, up from 100,000 last quarter. Deutsche Bank Ag now has $35.47B valuation. The stock declined 0.38% or $0.06 reaching $17.12 on the news. About 4.78M shares traded or 26.79% up from the average. Deutsche Bank AG (USA) (NYSE:DB) has risen 27.06% since October 25, 2016 and is uptrending. It has outperformed by 10.36% the SP500.

NUTRAFUELS (OTCMKTS:NTFU) had a decrease of 81.29% in short interest. NTFU’s SI was 6,400 shares in October as released by FINRA. Its down 81.29% from 34,200 shares previously. With 40,200 avg volume, 0 days are for NUTRAFUELS (OTCMKTS:NTFU)’s short sellers to cover NTFU’s short positions. About 1,544 shares traded. NutraFuels Inc (OTCMKTS:NTFU) has 0.00% since October 25, 2016 and is . It has underperformed by 16.70% the SP500.

NutraFuels, Inc. manufactures and distributes oral spray nutritional and dietary products. The company has market cap of $12.77 million. The Company’s oral spray products are designed to provide more absorption than capsules or liquid formulas. It currently has negative earnings. The Company’s products include NutraFuels sleep spray; NutraFuels Energy Spray; NutraFuels Garcinia Cambogia Spray; NutraFuels Headache and Pain Spray, and NutraFuels Hair, Skin and Nails Spray.

Among 14 analysts covering Deutsche Bank AG (NYSE:DB), 2 have Buy rating, 8 Sell and 4 Hold. Therefore 14% are positive. Deutsche Bank AG had 21 analyst reports since September 17, 2015 according to SRatingsIntel. The firm earned “Outperform” rating on Monday, April 24 by Macquarie Research. The stock of Deutsche Bank AG (USA) (NYSE:DB) has “Underperform” rating given on Friday, April 29 by Keefe Bruyette Woods. The firm has “Neutral” rating given on Friday, July 28 by Macquarie Research. The stock has “Sell” rating by DZ Bank AG on Thursday, March 23. The rating was downgraded by Bank of America to “Underperform” on Friday, July 29. The company was maintained on Friday, April 28 by DZ Bank AG. The rating was downgraded by HSBC to “Reduce” on Friday, August 11. The rating was downgraded by Macquarie Research to “Sell” on Tuesday, August 15. JP Morgan downgraded the stock to “Neutral” rating in Wednesday, October 28 report. The firm has “Hold” rating given on Thursday, September 21 by HSBC.

American Assets Investment Management Llc decreased Adobe Sys Inc (NASDAQ:ADBE) stake by 4,100 shares to 16,470 valued at $2.33 million in 2017Q2. It also reduced General Motors Co (NYSE:GM) stake by 30,190 shares and now owns 153,300 shares. Paypal Hldgs Inc was reduced too.

By Maria Brooks

Echostar Corporation-Receive News Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Dodgy herbal supplements are a common cause of liver injury, with bodybuilding and weight-loss products among the worst offenders.

US drug-induced liver injuries linked to supplements jumped from 7% in 2003 to about 20% in 2014, a study has found.

And studies in Europe show similar increases.

Last year, two cases of severe liver toxicity in Australian men — involving green tea extract, garcinia cambogia and valerian — prompted calls for tighter regulation.

In a new analysis of 272 herbal dietary supplements, 51% had inaccurate labelling, according to researchers presenting their findings at the annual meeting of the American Association for the Study of Liver Diseases.

“Herbal supplements are a common cause of liver injury,” says lead author Dr Victor Navarro, a hepatologist based in Philadelphia.

Dr Navarro is part of a group of investigators known as the Drug-Induced Liver Injury Network, supported by the US National Institute of Diabetes and Digestive and Kidney Diseases, which collects cases of drug-induced liver injury.

He says that, in 20% of cases, the injury is caused by dietary supplements.

Many of the products are sold as bodybuilding supplements or weight-loss supplements, he adds.

All of these cases have been reported to the US regulator, the Food and Drug Administration, but Dr Navarro says the next step is to build a stronger causality argument.

“We’ve identified some products we’re convinced cause liver injury, but right now it’s very circumstantial,” he says.

In Australia, herbal and dietary supplements are regulated by the TGA.